Your session is about to expire
← Back to Search
Study Summary
This trial is testing if a new drug is safe to take with alcohol.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 4 trial • 4 Patients • NCT05209867Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
How many participants are currently engaged in this clinical experimentation?
"Correct. According to clinicaltrials.gov, this research program is currently recruiting subjects and was first shared on May 9th 2022. The most recent update occurred on August 9th 2022 and the study seeks 30 people from one site."
What adverse effects could be caused by consuming CBD oil?
"Due to its status as a Phase 1 trial, the safety level of CBD oil was rated at 1 on our team's scale. This is because there are limited data sets that demonstrate both efficacy and security."
Does the research team permit seniors aged 75 and over to participate?
"The conditions for enrolment in this trial stipulate that patient must be over the age of 21 and under 65 years old."
What type of participant is best suited for this trial?
"Eligible participants must be adults between 21 and 65 years old with no pre-existing health conditions. A total of 30 people will be admitted to the trial."
Does this research currently accept new participants?
"The data posted on clinicaltrials.gov indicates that the recruitment process for this trial is underway, having begun on May 9th 2022 and receiving its most recent update on August 9th of the same year."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger